What chromosome is affected by Proteus syndrome?
What chromosome is affected by Proteus syndrome?
Researchers believe that this somatic mutation occurs randomly for no apparent reason (sporadically). Some researchers have attributed a subset of patients of Proteus syndrome to variants in the PTEN gene located on chromosome 10.
How is Proteus syndrome Detected?
Diagnosing Proteus syndrome The first step a doctor may take is to biopsy a tumor or tissue, and test the sample for the presence of a mutated AKT1 gene. If one is found, screening tests, such as X-rays, ultrasounds, and CT scans, may be used to look for internal masses.
Who is most likely to get Proteus syndrome?
Classically, males have been thought to be more commonly affected than females, but new studies with genetically confirmed cases have not yet been published. The genetic mutation that causes Proteus Syndrome is a somatic mutation that occurs after conception and is propagated in one or more subsets of embryonic cells.
Can animals have Proteus syndrome?
Interestingly, 27 of 31 Proteus syndrome animals had non-zero blood VAF that is in contrast to the human disorder where it is rarely seen in peripheral blood.
Where did Proteus syndrome originate?
Proteus syndrome results from a mutation in the AKT1 gene. This genetic change is not inherited from a parent; it arises randomly in one cell during the early stages of development before birth. As cells continue to grow and divide, some cells will have the mutation and other cells will not.
What causes Elephant Man?
Only a few hundred people in the world have Proteus syndrome, a bizarre condition in which a mutant gene causes asymmetrical growth of body parts. The syndrome can be horribly disfiguring, as you can see in this illustration of Joseph Merrick, the 19th Century Englishman who became known as the Elephant Man.
How is Proteus syndrome caused?
Where is Proteus found?
Proteus is found abundantly in soil and water, and although it is part of the normal human intestinal flora (along with Klebsiella species, and Escherichia coli), it has been known to cause serious infections in humans.
Who first discovered Proteus syndrome?
Medical literature through the 20th century contains other descriptions of the disorder. Canadian-based geneticist Michael Cohen, Jr., DMD, Ph. D., first described the condition in 1979, and Hans Rudolf Wiedemann, a German pediatrician gave the disease its name in 1983.
What causes Proteus syndrome?
What diseases are caused by P vulgaris?
P. vulgaris, previously considered biogroup 2, has been reported to cause UTIs, wound infections, burn infections, bloodstream infections, and respiratory tract infections (71, 137).
What disease did John Merrick?
The disorder from which Merrick suffered was long thought to be an extremely severe case of neurofibromatosis, but his deformities were probably the result of an extremely rare disease known as Proteus syndrome.
What makes Proteus syndrome a rare genetic disorder?
Proteus syndrome is a rare disorder characterized by overgrowth of various tissues of the body. The cause of the disorder is a mosaic variant in a gene called AKT1. Disproportionate, asymmetric overgrowth occurs in a mosaic pattern (i.e., a random “patchy” pattern of affected and unaffected areas).
What are the physical features of Proteus syndrome?
Proteus syndrome is a highly variable, severe disorder of asymmetric and disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations. Specific features include cerebriform connective tissue nevus, thin limbs, lipomas, and lung cysts.
How is the overgrowth of Proteus syndrome treated?
Treatment of the overgrowth include orthopedic procedures to delay or stop linear bone growth and correction of skeletal deformities such as scoliosis. Developmental intervention or special education is suggested for developmental delays.
When do newborns with Proteus syndrome show signs?
Newborns with Proteus syndrome have few or no signs of the disorder. Overgrowth becomes apparent between the ages of 6 and 18 months and becomes more severe with age. It may result in differences in appearance and with time, an increased risk for blood clots and tumors.
